Perspective Therapeutics Stock Performance
as on September 24, 2026 at 2:16 pm IST
Day's Low
Day's High
$2.50$2.90
4.58%
Downside
10.69%
Upside
52 Week's Low
52 Week's High
$1.96$6.1625.38%
Downside
135.11%
Upside
Perspective Therapeutics share price movements today
- Previous Close
- $2.96
- Open
- $2.90
- Volume
- 3.0M
- Market Cap
- $337.9M
- Day's Low - High
- $2.50 - $2.90
- 52 Week Low - High
- $1.96 - $6.16
Perspective Therapeutics Historical Returns
- 1 Month Return
- -17.87 %
- 3 Month Return
- -12.67 %
- 1 Year Return
- -19.63 %
- 3 Year Return
- -12.23 %
- 5 Year Return
- 0 %
Perspective Therapeutics Stock Fundamentals & Key Indicators
Check Perspective Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$337.9M
EPS (TTM)
-1.56
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.9
Industry PE ratio
-6.13
PEG Ratio
0.10693895197553148
EBITDA
-116.2M
Revenue (TTM)
366.0K
Profit Margin
-419.40%
Return On Equity TTM
-41.56%
Perspective Therapeutics Stock Valuation
Track how Perspective Therapeutics P/E has moved over time to understand its valuation trends.
Perspective Therapeutics in the last 5 years
Lowest (-23.72x)
June 30, 2021
Industry (-6.13x)
December 31, 2025
Today (-1.96x)
December 31, 2025
Highest (-1.96x)
December 31, 2025
Today’s Price to Earnings Ratio: -1.96x
Perspective Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Perspective Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $337.9M | NA | -1.9 | -419.40% | 0.00% | |
| Buy | $51.2B | -27.69% | 51.02 | 77.98% | 0.00% | |
| Buy | $117.4B | -31.32% | 22.19 | 66.69% | 3.14% | |
| StrongBuy | $178.2B | -16.79% | 33.35 | 56.80% | 2.39% | |
| StrongBuy | $105.2B | -1.17% | 28.27 | 65.17% | 1.27% |
Stock Returns calculator for Perspective Therapeutics Stock including INR - Dollar returns
The Perspective Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Perspective Therapeutics investment value today
Current value as on today
₹86,641
Returns
Returns from Perspective Therapeutics Stock
Dollar Impact
₹6,273 (+6.27%)
Analyst Recommendation on Perspective Therapeutics Stock
Based on 10 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Perspective Therapeutics. Average target price of $12.29
Perspective Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Perspective Therapeutics.
What analysts predicted
78.68%UPSIDE
Target Price
$12.29
Current Price
$2.62
Analyzed by
10 Analysts
Target
$12.29
Perspective Therapeutics target price $12.29, a slight upside of 78.68% compared to current price of $2.62. According to 10 analysts rating.
Indian Investors' Interest in Perspective Therapeutics Stock
Search interest for Perspective Therapeutics Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Perspective Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Perspective Therapeutics Annual Profit & Loss
All numbers in Millions USD
Perspective Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Perspective Therapeutics Annual Cash Flow
All numbers in Millions USD
Perspective Therapeutics News & Key Events
Today's Timeline - 14 September
Mon, 04:18 PM
-Perspective Therapeutics announces collaboration with Merck to evaluate PSV359 with Keytruda in solid tumors under a Phase 1/2a trial.
Insights on Perspective Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 43.0K → 81.0K (in $), with an average increase of 24.8% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Edwards Lifesciences Corp has given 16.3% return, outperforming this stock by 35.9%
- NO EFFECT
Against Peers
In the last 3 years, Edwards Lifesciences Corp has given 24.6% return, outperforming this stock by 36.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -26.18M → -26.78M (in $), with an average decrease of 2.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, CATX stock has moved down by -9.0%
About Perspective Therapeutics
| Organisation | Perspective Therapeutics |
| Headquarters | 2401 Elliott Avenue, Seattle, WA, 98121, US |
| Industry | Medical - Devices |
| CEO | Johan Spoor |
| E-voting on shares | Click here to vote |
Key Management of Perspective Therapeutics
Name | Title |
|---|---|
Dr. Paul Lyne Ph.D. | Chief Science Officer |
Mr. Shane Cobb | Executive Vice President of Operations |
Mr. Jonathan R. Hunt | Chief Accounting Officer |
Ms. Annie J. Cheng | Vice President of Investor Relations |
Mr. Chris Nenno | General Counsel & Corporate Secretary |
Mr. Johan M. Spoor | CEO & Director |
Mr. Joel David Sendek | CFO & Principal Financial Officer |
Dr. Markus Puhlmann M.B.A., M.D. | Chief Medical Officer |
Dr. Michael K. Schultz Ph.D. | Co-Founder & Senior Scientific Advisor |
Mr. Andrew Bright | Executive Vice President of Brachytherapy |
FAQs
What is Perspective Therapeutics share price today?
Perspective Therapeutics share price today is $2.62 as on at the close of the market. Perspective Therapeutics share today touched a day high of $2.90 and a low of $2.50.
What is the 52 week high and 52 week low for Perspective Therapeutics share?
Perspective Therapeutics share touched a 52 week high of $6.16 on and a 52 week low of $1.96 on . Perspective Therapeutics stock price today i.e. is closed at $2.62,which is 57.47% down from its 52 week high and 34.02% up from its 52 week low.
What is Perspective Therapeutics's market capitalisation today?
Perspective Therapeutics market capitalisation is $0.00T as on .
How to invest in Perspective Therapeutics Stock (CATX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Perspective Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Perspective Therapeutics Shares that will get you 0.5725 shares as per Perspective Therapeutics share price of $2.62 per share as on September 24, 2026 at 8:46 am IST.
What is the minimum amount required to buy Perspective Therapeutics Stock (CATX) from India?
Indian investors can start investing in Perspective Therapeutics (CATX) shares with as little as ₹95.74 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.40 in Perspective Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Perspective Therapeutics share’s latest price of $2.62 as on September 24, 2026 at 8:46 am IST, you will get 3.8168 shares of Perspective Therapeutics. Learn more about
fractional shares .